These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 11869833

  • 1. The enhanced bladder cancer susceptibility of NAT2 slow acetylators towards aromatic amines: a review considering ethnic differences.
    Golka K, Prior V, Blaszkewicz M, Bolt HM.
    Toxicol Lett; 2002 Mar 10; 128(1-3):229-41. PubMed ID: 11869833
    [Abstract] [Full Text] [Related]

  • 2. Polymorphism of N-acetyltransferase 2 (NAT2) gene polymorphism in shanghai population: occupational and non-occupational bladder cancer patient groups.
    Ma QW, Lin GF, Chen JG, Xiang CQ, Guo WC, Golka K, Shen JH.
    Biomed Environ Sci; 2004 Sep 10; 17(3):291-8. PubMed ID: 15602826
    [Abstract] [Full Text] [Related]

  • 3. NAT2 slow acetylation and bladder cancer in workers exposed to benzidine.
    Carreón T, Ruder AM, Schulte PA, Hayes RB, Rothman N, Waters M, Grant DJ, Boissy R, Bell DA, Kadlubar FF, Hemstreet GP, Yin S, LeMasters GK.
    Int J Cancer; 2006 Jan 01; 118(1):161-8. PubMed ID: 16003747
    [Abstract] [Full Text] [Related]

  • 4. Occupational history and genetic N-acetyltransferase polymorphism in urothelial cancer patients of Leverkusen, Germany.
    Golka K, Prior V, Blaszkewicz M, Cascorbi I, Schöps W, Kierfeld G, Roots I, Bolt HM.
    Scand J Work Environ Health; 1996 Oct 01; 22(5):332-8. PubMed ID: 8923605
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The impact of interindividual variation in NAT2 activity on benzidine urinary metabolites and urothelial DNA adducts in exposed workers.
    Rothman N, Bhatnagar VK, Hayes RB, Zenser TV, Kashyap SK, Butler MA, Bell DA, Lakshmi V, Jaeger M, Kashyap R, Hirvonen A, Schulte PA, Dosemeci M, Hsu F, Parikh DJ, Davis BB, Talaska G.
    Proc Natl Acad Sci U S A; 1996 May 14; 93(10):5084-9. PubMed ID: 8643532
    [Abstract] [Full Text] [Related]

  • 8. N-acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark.
    Lower GM, Nilsson T, Nelson CE, Wolf H, Gamsky TE, Bryan GT.
    Environ Health Perspect; 1979 Apr 14; 29():71-9. PubMed ID: 510245
    [Abstract] [Full Text] [Related]

  • 9. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H, Sigsgaard T, Wolf H, Autrup H.
    Cancer Epidemiol Biomarkers Prev; 1997 Apr 14; 6(4):225-31. PubMed ID: 9107426
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Joint effects of the N-acetyltransferase 1 and 2 (NAT1 and NAT2) genes and smoking on bladder carcinogenesis: a literature-based systematic HuGE review and evidence synthesis.
    Sanderson S, Salanti G, Higgins J.
    Am J Epidemiol; 2007 Oct 01; 166(7):741-51. PubMed ID: 17675654
    [Abstract] [Full Text] [Related]

  • 12. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
    Thier R, Brüning T, Roos PH, Rihs HP, Golka K, Ko Y, Bolt HM.
    Int J Hyg Environ Health; 2003 Jun 01; 206(3):149-71. PubMed ID: 12872524
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. N-acetyltransferase 2 phenotype in painters with bladder cancer and controls.
    Golka K, Weistenhofer W, Jedrusik P, Geller F, Blaszkewicz M, Bolt HM.
    Ann Acad Med Singap; 2001 Sep 01; 30(5):464-7. PubMed ID: 11603126
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. N-acetyltransferase 2 phenotype, occupation, and bladder cancer risk: results from the EPIC cohort.
    Pesch B, Gawrych K, Rabstein S, Weiss T, Casjens S, Rihs HP, Ding H, Angerer J, Illig T, Klopp N, Bueno-de-Mesquita B, Ros MM, Kaaks R, Chang-Claude J, Roswall N, Tjønneland A, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Dossus L, Boeing H, Weikert S, Trichopoulos D, Palli D, Sieri S, Tumino R, Panico S, Quirós JR, González C, Sánchez MJ, Dorronsoro M, Navarro C, Barricarte A, Ljungberg B, Johansson M, Ulmert D, Ehrnström R, Khaw KT, Wareham N, Key TJ, Ferrari P, Romieu I, Riboli E, Brüning T, Vineis P.
    Cancer Epidemiol Biomarkers Prev; 2013 Nov 01; 22(11):2055-65. PubMed ID: 24092628
    [Abstract] [Full Text] [Related]

  • 17. N-Acetyltransferase 2 (NAT2) and Glutathione S-Transferase µ (GSTM1) in Bladder-cancer Patients in a Highly Industrialized Area.
    Golka K, Reckwitz T, Kempkes M, Cascorbi I, Blaskewicz M, Reich SE, Roots I, Soekeland J, Schulze H, Bolt HM.
    Int J Occup Environ Health; 1997 Apr 01; 3(2):105-110. PubMed ID: 9891107
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Acetyltransferases and susceptibility to chemicals.
    Hein DW, Rustan TD, Doll MA, Bucher KD, Ferguson RJ, Feng Y, Furman EJ, Gray K.
    Toxicol Lett; 1992 Dec 01; 64-65 Spec No():123-30. PubMed ID: 1471166
    [Abstract] [Full Text] [Related]

  • 20. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis.
    Hein DW.
    Mutat Res; 2002 Sep 30; 506-507():65-77. PubMed ID: 12351146
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.